Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUTT, M. S. R.
Right arrow Articles by WETHERLEY-MEIN, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUTT, M. S. R.
Right arrow Articles by WETHERLEY-MEIN, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Next Article next article arrow

Blood, 1953, Vol. 8, No. 4, pp. 295-314.
© 1953 American Society of Hematology, Inc.


The Myeloproliferative Disorders With Special Reference to Myelofibrosis

M. S. R. HUTT M.D., M.R.C.P.1, J. L. PINNIGER D.M., M.R.C.P.1, and G. WETHERLEY-MEIN M.B., B.CHIR.1

1 Louis Jenner Laboratory, St. Thomas’s Hospital and Medical School London, England.

1. The clinical, hematologic and histologic findings in 10 patients with primary proliferative marrow disorders are presented.

2. It is considered that these findings indicate that myelofibrosis, myeloid leukemia, megakaryocytic myelosis and probably polycythemia vera are similar and related processes.

3. It is suggested that this relationship may be regarded as an example of a proliferative or neoplastic process involving multipotential primitive mesenchymal cells.

4. The significance of splenomegaly in myelofibrosis, the nature of extramedullary hemopoiesis and the relationship between this group of marrow disorders and the primary lymph node tumours are briefly discussed.

Submitted on September 23, 1952
Accepted on October 20, 1952


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. M. Cohen
Chronic Myelogenous Leukemia With Myelofibrosis: Four Years After Auto-immune Hemolytic Anemia
Arch Intern Med, June 1, 1967; 119(6): 620 - 625.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
E. W. HEINLE JR., H. O. SARASTI, D. GARCIA, J. J. KENNY, and M. P. WESTERMAN
Polycythemia Vera Associated With Lymphomatous Diseases and Myeloma
Arch Intern Med, October 1, 1966; 118(4): 351 - 355.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
D. R. KORST, D. V. CLATANOFF, and R. F. SCHILLING
On Myelofibrosis
Arch Intern Med, February 1, 1956; 97(2): 169 - 183.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C.-S. WRIGHT, D. S. MABRY, R. D. CARR, and A. M. PERRY
SURVEY OF THE 1953 HEMATOLOGY LITERATURE
Arch Intern Med, December 1, 1954; 94(6): 995 - 1036.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1953 by American Society of Hematology         Online ISSN: 1528-0020